24 results on '"Oppi, Sara"'
Search Results
2. Laparoscopic management of isolated nodal recurrence in gynecological malignancies is safe and feasible even for large metastatic nodes up to 8 cm: A prospective case series
3. COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
4. Additional file 1 of Genetic deletion of hepatic NCOR1 protects from atherosclerosis by promoting alternative bile acid-metabolism and sterol excretion
5. Infection Risk Evaluation Based on a Novel Scoring System in Chronic Lymphocytic Leukemia (CLL) Patients at Diagnosis
6. Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report
7. Defibrotide Has a Role in COVID-19 Therapy
8. Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine
9. Diagnostic Framework of Pelvic Massive Necrosis with Peritonitis following Chemoradiation for Locally Advanced Cervical Cancer: When Is the Surgery Not Demandable? A Case Report and Literature Review
10. Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature
11. Experimental Drugs for Chemotherapy- and Cancer-Related Anemia
12. Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer
13. Defibrotide in the COVID‐19 coagulopathy: What is the timing?
14. Cachexia as Evidence of the Mechanisms of Resistance and Tolerance during the Evolution of Cancer Disease
15. Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
16. Deletion of fibroblast activation protein provides atheroprotection
17. Mouse Models for Atherosclerosis Research—Which Is My Line?
18. Deletion of fibroblast activation protein provides atheroprotection.
19. Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature
20. Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature.
21. The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma
22. Homozygosity for Killer Immunoglobin-like Receptor (KIR) Haplotype a Is Associated to Negative Interim Positron Emission Tomography (PET) and a Favourable Outcome in Hodgkin Lymphoma
23. Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
24. Relapsing/refractory HL after autotransplantation: which treatment?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.